1. Membrane Transporter/Ion Channel
  2. SGLT


SGLT (Sodium-dependent glucose cotransporters) are a family of glucose transporter found in the intestinal mucosa (enterocytes) of the small intestine (SGLT1) and the proximal tubule of the nephron (SGLT2 in PCT and SGLT1 in PST). SGLT contribute torenal glucose reabsorption. In the kidneys, 100% of the filtered glucose in the glomerulus has to be reabsorbed along the nephron (98% in PCT, via SGLT2). In case of too high plasma glucose concentration (hyperglycemia), glucose is excreted in urine (glucosuria); because SGLT are saturated with the filtered monosaccharide. Glucose is never secreted by the nephron. There are two most well known members of SGLT family are SGLT1 and SGLT2, which are members of the SLC5A gene family. Inhibition of SGLT2 leads to a reduction in blood glucose levels. Therefore, SGLT2 inhibitors have potential use in the treatment of type II diabetes.

SGLT 相关产品 (18):

Cat. No. Product Name Effect Purity
  • HY-15409
    Empagliflozin Inhibitor 99.91%
    Empagliflozin是一种选择性钠葡萄糖协同转运蛋白-2 (SGLT-2) 抑制剂,抑制人SGLT-2的IC50 为3.1 nM。
  • HY-10450
    Dapagliflozin Inhibitor 99.85%
    Dapagliflozin (BMS-512148) 是用于治疗2型糖尿病的钠-葡萄糖共转运蛋白2 (SGLT2)抑制剂。
  • HY-10451
    Canagliflozin Inhibitor 99.61%
    Canagliflozin是选择性的 SGLT2 抑制剂,在mSGLT2,rSGLT2和hSGLT2细胞中的IC50分别为2 nM,3.7 nM和4.4 nM。
  • HY-N0143
    Phlorizin Inhibitor
    Phlorizin 是一种非选择性的 SGLT 抑制剂,对于 hSGLT1hSGLT2Ki 值分别为 300 和 39 nM。Phlorizin 也是一个 Na+/K+-ATPase 抑制剂。
  • HY-N0142
    Phloretin Inhibitor 99.70%
    Phloretin(NSC 407292; RJC 02792)是天然多酚,能抑制通过SGLT1、SGLT2和GLUT1的葡萄糖转运。
  • HY-101782
    HSK0935 Inhibitor
    HSK0935是高效,高选择性,口服可用的 SGLT2 抑制剂。IC50为1.3 nM。具有抗高血糖功效。
  • HY-15461A
    Ertugliflozin L-pyroglutamic acid Inhibitor 99.98%
    Ertugliflozin (PF-04971729) L-pyroglutamic acid 是有效的、选择性的、具有口服活性的钠离子依赖的葡萄糖协同转运蛋白2 (SGLT2) 的有效选择性抑制剂。其对h-SGLT2 的 IC50 值为0.877 nM。是一种治疗2型糖尿病的临床药物。
  • HY-15516
    Sotagliflozin Inhibitor 99.99%
    Sotagliflozin (LX-4211) 是SGLT1/2抑制剂,是抗糖尿病剂。
  • HY-15461
    Ertugliflozin Inhibitor 99.80%
    Ertugliflozin (PF-04971729) 是有效的、选择性的、具有口服活性的钠离子依赖的葡萄糖协同转运蛋白2 (SGLT2) 的抑制剂。其对h-SGLT2 的 IC50 值为0.877 nM。是一种治疗2型糖尿病的临床药物。
  • HY-I0383
    Canagliflozin hemihydrate Inhibitor 99.95%
    Canagliflozin(JNJ 28431754; TA 7284)半水合物是高活性的hSGLT2选择性抑制剂,IC50为2.2 nM,比对hSGLT1的抑制性高400倍。
  • HY-13413
    Tofogliflozin hydrate Inhibitor 99.41%
  • HY-17604
    Bexagliflozin Inhibitor 99.48%
    Bexagliflozin是强的,有选择性的SGLT2抑制剂。在SGLT1 /SGLT2中IC50分别是5.6 μM /2 nM
  • HY-109092
    Licogliflozin Inhibitor 98.53%
    Licogliflozin 是一种钠-葡萄糖协同转运蛋白 (SGLT1SGLT2) 抑制剂。
  • HY-10450A
    Dapagliflozin ((2S)-1,2-propanediol, hydrate) Inhibitor 99.61%
  • HY-14894
    Ipragliflozin Inhibitor 98.67%
    Ipragliflozin (ASP1941)是高活性SGLT2选择性抑制剂,IC50为2.8 nM,对SGLT1/3/4/5/6几乎无活性。
  • HY-14902
    Tofogliflozin Inhibitor
  • HY-14894A
    Ipragliflozin L-Proline Inhibitor
    Ipragliflozin (L-Proline) 是 SGLT2 高活性的,选择性抑制剂,IC50 为 2.8 nM,对 SGLT1/3/4/5/6 几乎无活性。
  • HY-109018
    Velagliflozin Inhibitor
    Velagliflozin 是一种可口服的钠-葡萄糖协同转运蛋白 2 (SGLT2) 抑制剂,具有抗糖尿病的活性。
Isoform Specific Products

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.